| 1 |
Wang GX, Zhao XY, Meng ZX, et al. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis [J]. Nat Med, 2014, 20(12): 1436-1443.
|
| 2 |
Chen LL, Peng MM, Zhang JY, et al. Elevated circulating neuregulin4 level in patients with diabetes [J]. Diabetes Metab Res Rev, 2017, 33(4): e2870.
|
| 3 |
Kang YE, Kim JM, Choung S, et al. Comparison of serum Neuregulin 4 (Nrg4) levels in adults with newly diagnosed type 2 diabetes mellitus and controls without diabetes [J]. Diabetes Res Clin Pract, 2016, 117: 1-3.
|
| 4 |
Dai YN, Zhu JZ, Fang ZY, et al. A case-control study: Association between serum neuregulin 4 level and non-alcoholic fatty liver disease [J]. Metabolism, 2015, 64(12): 1667-1673.
|
| 5 |
Cai CF, Lin Mz, Xu YF, et al. Association of circulating neuregulin 4 with metabolic syndrome in obese adults: a cross-sectional study [J]. BMC Med, 2016, 14(1): 165.
|
| 6 |
Temur M, Calan M, Akşit M, et al. Increased serum neuregulin 4 levels in women with polycystic ovary syndrome: a case-control study [J]. Ginekol Pol, 2017, 88(10): 517-522.
|
| 7 |
Jiang J, Lin M, Xu Y, et al. Circulating neuregulin 4 levels are inversely associated with subclinical cardiovascular disease in obese adults [J]. Sci Rep, 2016, 6: 36710.
|
| 8 |
Bublil EM, Yarden Y. The EGF receptor family: spearheading a merger of signaling and therapeutics [J]. Curr Opin Cell Biol, 2007, 19: 124-134.
|
| 9 |
Gumà A, Martínez-Redondo V, López-Soldado I, et al. Emerging role of neuregulin as a modulator of muscle metabolism [J]. Am J Physiol Endocrinol Metab, 2010, 298(4): E742-E750.
|
| 10 |
Harari D, Tzahar E, Romano J, et al. Neuregulin-4:a novel growth factor that acts through the ErbB-4 receptor tyro sinekinase [J]. Oncogene, 1999, 18(17): 2681-2689.
|
| 11 |
Rosell M, Kaforou M, Frontini A, et al. Brown and white adipose tissues: intrinsic differences in gene expression and response to cold exposure in mice [J]. Am J Physiol Endocrinol Metab, 2014, 306(8): E945-E964.
|
| 12 |
Wu J, Bostrom P, Sparks LM, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human [J]. Cell, 2012, 150(2): 366-376.
|
| 13 |
Pfeifer A. NRG4: An endocrine link between brown adipose tissue and liver [J]. Cell Metab, 2015, 21(1): 13-14.
|
| 14 |
McElroy SJ, Castle SL, Bernard JK, et al. The ErbB4 ligand neuregulin-4 protects against experimental necrotizing enterocolitis [J]. Am J Pathol, 2014, 184(10): 2768-2778.
|
| 15 |
Chen ZM, Wang GX, Ma SL, et al. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders [J]. Mol Metab, 2017, 6(8): 863-872.
|
| 16 |
Ma YJ, Gao MM, Liu D. Preventing high fat diet-induced obesity and improving insulin sensitivity through neuregulin 4 gene Transfer [J]. Sci Rep, 2016, 6: 26242.
|
| 17 |
South JC, Blackburn E, Brown IR, et al. The neuregulin system of ligands and their receptors in rat islets of langerhans [J]. Endocrinology, 2013, 154(7): 2385-2392.
|
| 18 |
Zhang L, Fu YM, Zhou N, et al. Circulating neuregulin 4 concentrations in patients with newly diagnosed type 2 diabetes: a cross-sectional study [J]. Endocrine, 2017, 57(3): 535-538.
|
| 19 |
Yan PJ, Xu Y, Wan Q, et al. Plasma Neuregulin 4 levels are associated with metabolic syndrome in patients newly diagnosed with type 2 diabetes mellitus [J]. Dis Markers, 2018, 2018(3): 1-11.
|
| 20 |
Kurek EM, Yayla AC, Sahin EG, et al. Clinical significance of neuregulin 4 (NRG4) in gestational diabetes mellitus [J]. Gynecol Endocrinol, 2018, 34(7): 605-608.
|
| 21 |
Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society [J]. J Am Coll Cardiol, 2014, 63(25 Pt B): 2985-3023.
|
| 22 |
Bernard JK, McCann SP, Bhardwaj V, et al. Neuregulin-4 is a survival factor for colon epithelial cells both in culture and in vivo [J]. J Biol Chem, 2012, 287(47): 39850-39858.
|
| 23 |
Feng YJ, Teitelbaum DH. Epidermal growth factor/TNF-α transactivation modulates epithelial cell proliferation and apoptosis in a mouse model of parenteral nutrition [J]. Am J Physiol Gastrointest Liver Physiol, 2012, 302(2): G236-G249.
|
| 24 |
Schumacher MA, Hedl M, Abraham C, et al. ErbB4 signaling stimulates pro-inflammatory macrophage apoptosis and limits colonic inflammation [J]. Cell Death Dis, 2017, 8(2): e2622.
|
| 25 |
Yan PJ, Xu Y, Wan Q, et al. Decreased plasma neuregulin 4 concentration is associated with increased high-sensitivity C-reactive protein in newly diagnosed type 2 diabetes mellitus patients: a cross-sectional study [J]. Acta Diabetol, 2017, 54(12): 1091-1099.
|
| 26 |
de Mutsert R, Sun Q, Willett WC, et al. Overweight in early adulthood, adult weight change, and risk of type 2 diabetes, cardiovascular diseases, and certain cancers in men: a cohort study [J]. Am J Epidemiol, 2014, 179: 353-1365.
|
| 27 |
Liu L, Miura K, Fujiyoshi A, et al. Impact of metabolic syndrome on the risk of cardiovascular disease mortality in the United States and in Japan [J]. Am J Cardiol, 2014, 113(1): 84-89.
|
| 28 |
Tao LX, Li X, Zhu HP, et al. Association of hematological parameters with metabolic syndrome in Beijing adult population: a longitudinal study [J]. Endocrine, 2014, 46(3): 485-495.
|
| 29 |
Aguilar M, Bhuket T, Torres S, et al. Prevalence of the metabolic syndrome in the United States, 2003-2012 [J]. JAMA, 2015, 313(19): 1973-1974.
|
| 30 |
Andrus B, Lacaille D. 2013 ACC/AHA guideline on the assessment of cardiovascular risk [J]. J Am Coll Cardiol, 2014, 63(25): 2886.
|
| 31 |
Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society [J]. J Am Coll Cardiol, 2014, 63(25): 2985-3023.
|
| 32 |
Mendez-Sanchez N, Arrese M, Zamora-Valdes D, et al. Current concepts in the pathogenesis of nonalcoholic fatty liver disease [J]. Liver Int, 2007, 27(4): 423-433.
|
| 33 |
Stefan N, Schick F, Häring HU, et al. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease [J]. N Engl J Med, 2014, 371(23): 2237-2238.
|
| 34 |
den Engelsen C, Koekkoek PS, Gorter KJ, et al. High-sensitivity C-reactive protein to detect metabolic syndrome in a centrally obese population: a cross-sectional analysis [J]. Cardiovascular Diabetology, 2012, 11(1): 25.
|
| 35 |
Liu SQ, Tefft BJ, Roberts DT, et al. Cardioprotective proteins upregulated in the liver in response to experimental myocardial ischemia [J]. Am J Physiol Heart Circ Physiol, 2012, 303(12): H1446-H1458.
|